Opendata, web and dolomites


“Multi-component nanoparticles as bimodal contrast agents for MRI and optical detection of tumors and for targeted photodynamic therapy”

Total Cost €


EC-Contrib. €






 MCNANO project word cloud

Explore the words cloud of the MCNANO project. It provides you a very rough idea of what is the project "MCNANO" about.

excitation    photoluminescence    phototheranostic    express    components    therapeutic    photoactivated    doped    multidisciplinary    nano    moieties    t2    functionalization    drug    receptors    tissues    ions    mri    efficacy    platform    yield    spectroscopy    agents    emitted    bimodal    first    combines    oh    py    lanthanide    cyclic    offers    simultaneously    detection    nanomatrix    cells    ultimately    n3    anti    contrast    modular    acid    anchoring    infrared    chemistry    treatment    exhibit    fluoride    imaging    optical    photo    synthesis    visible    core    cancer    combination    will    bio    nanoprobes    rgd    soluble    water    suitable    cure    tm3    disruptive    emission    decorated    degree    biocompatible    nanoparticle    shell    tb3    rare    tumor    containing    surface    pt    980    efficient    of    nh2    synthesize    agent    time    blue    excited    attaching    upconverting    nanoparticles    upconverted    strategies    er3    active    earth    ho3    area    simultaneous    clinical    folic    cholesterol    region    light    diagnosis    dy3    covered   

Project "MCNANO" data sheet

The following table provides information about the project.


Organization address
address: OUDE MARKT 13
city: LEUVEN
postcode: 3000

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Project website
 Total cost 172˙800 €
 EC max contribution 172˙800 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2015
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2016
 Duration (year-month-day) from 2016-04-01   to  2018-03-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

The main aim of this proposal is to synthesize a range of lanthanide containing nanoparticles with an upconverting core, that can be excited in the infrared region to yield emission in the visible range, as for MRI and optical imaging. The nanoparticles will be covered with a rare earth doped MRI active shell and decorated with targeting moieties, which offers a means of targeting cancer cells that greatly over express the receptors. Further we will develop “phototheranostic” agents by anchoring the photo active anti cancer drug in between the receptors and the surface of upconverting/MRI active nanoparticle. A platform for synthesis of water soluble, modular target specific bimodal agents based on nanoprobes will be developed that will exhibit efficient upconverted photoluminescence from the rare-earth ions (Er3/Tm3) doped into fluoride nanomatrix. Simultaneously, the Tb3/Dy3/Ho3 present at the shell will make them suitable as T2 contrast agents for MRI. Specific tumor targeting strategies will be developed by attaching targeting components like folic acid, cholesterol or cyclic-RGD to the surface of the nanoparticles. Functionalization of nanoparticles with [Pt(N3)2(OH)2(NH2-R)(py)] drug, which can be photoactivated by the blue light emitted from the nanoparticle core upon excitation at 980, will result in a novel phototheranostic anti-cancer agent. This system may allow a large degree of control of the therapeutic efficacy and ultimately lead to simultaneous diagnosis and treatment in clinical applications. The unique multidisciplinary approach adopted here which combines areas of nano-chemistry, spectroscopy and bio-imaging, is expected to lead to a disruptive change in the area of cancer research. The combination of these areas would allow for the first time the development of biocompatible “phototheranostic” agents for the simultaneous detection by MRI/optical imaging and cure of the cancer- affected tissues.


year authors and title journal last update
List of publications.
2018 Silvanose Biju, Juan Gallo, M. Bañobre-López, Bella B. Manshian, Stefaan J. Soenen, Uwe Himmelreich, Luce Vander Elst, Tatjana N. Parac-Vogt
A Magnetic Chameleon: Biocompatible Lanthanide Fluoride Nanoparticles with Magnetic Field Dependent Tunable Contrast Properties as a Versatile Contrast Agent for Low to Ultrahigh Field MRI and Optical Imaging in Biological Window
published pages: , ISSN: 0947-6539, DOI: 10.1002/chem.201801814
Chemistry - A European Journal 2019-06-13
2018 Silvanose Biju, Tatjana Parac-Vogt
Recent Advances in Lanthanide Based Nano-architectures as Probes for Ultra High-Field Magnetic Resonance Imaging
published pages: , ISSN: 0929-8673, DOI: 10.2174/0929867325666180201110244
Current Medicinal Chemistry 25 2019-06-13

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MCNANO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MCNANO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

PNAIC (2018)

Positive and Negative Asymmetry in Intergroup Contact: Its Impact on Linguistic Forms of Communication and Physiological Responses

Read More  

NaWaTL (2020)

Narrative, Writing, and the Teotihuacan Language: Exploring Language History Through Phylogenetics, Epigraphy and Iconography

Read More  

TIPTOP (2019)

Tensoring Positive Maps on Operator Structures

Read More